Business Review Nov 14 24
BR Interview | Johnson & Johnson driving healthcare innovation in Romania:
BR Exclusive - Having been present on the local market for more than 30 years now ...
business-review.eu/br-exclusive/br-interview-johnson-johnson-driving-healthcare-innovation-in-romania-274668
Photo: business-review.eu · view article
Key FactsJohnson & Johnson: Pioneering Healthcare Innovation in Romania
Nov 14, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: business-review.eu
Summary created with AI assistance · Source: business-review.eu
- Johnson & Johnson has been dedicated to Romanian society for over 30 years, focusing on education and health.
- The company offers scholarships to medical students and promotes digital health innovations through university partnerships.
- The Hackathon4Health initiative allows young innovators to develop their ideas with funding and mentorship from Johnson & Johnson and the university.
- Future goals include combating cancer with numerous new drug approvals planned by 2030.
Story Details
| Last Updated | |
| Total Articles | 2 |
Main Topics
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
application of better solutions that meet new requirements, inarticulated needs, or existing market needs
News on this topic
Cointelegraph Nov 14 24
⚡ LATEST: In the past four days, $ETH's market cap has surpassed that of Netflix and Johnson & Johnson.
Business Review Nov 14 24
BR Interview | Johnson & Johnson driving healthcare innovation in Romania: BR Exclusive - Having been present on the local market for more than 30 years now ...
business-review.eu/br-exclusive/br-interview-johnson-johnson-driving-healthcare-innovation-in-romania-274668
Similar to This
Previous
Biocon expands global reach of Stelara biosimilar to nine more markets: Biocon Expansion: The biosimilar to Johnson & Johnson's Stelara will be commercialised in ...
business-standard.com/companies/news/biocon-yesintek-stelara-biosimilar-market-entry-nine-countries-126102600145_1.html
Johnson & Johnson’s prostate cancer drug shrinks tumours in early-stage trial: JNJ-6143 demonstrates strong PSA reduction in advanced cases
ebx.sh/IxIUB5
Meet the Corporations Funding Ramaswamy's Vicious Attack Ad on Acton: Corporate PACs for Bank of America, Deloitte, Kroger, Pfizer, Johnson & Johnson ...
commondreams.org/news/ramaswamy-attack-ad-corporations
Hundreds of Californians Just Sued Carefree Over PFAS. Now the Case Hinges on 2 Words
inc.com/lucia-auerbach/californians-just-sued-carefree-over-pfas-now-case-hinges-2-words/91423490
Barron's Oct 21
Why This Pharma Pro Likes Johnson & Johnson, Eli Lilly, and Merck Stock: Despite rising interest rates and the uncertainty of midterm elections ...
barrons.com/articles/goldman-sachs-pharma-johnson-johnson-eli-lilly-merck-stock-0087bbd7
Paid articlePaywall
Ovarian cancer due to talcum powder? Sufferers in Great Britain fight for answers in court
op-online.de/welt/eierstockkrebs-wegen-babypuder-betroffene-kaempfen-gericht-talkum-johnson-and-johnson-zr-94549669.html
Multiple Myeloma: A Cure in Sight?: In Austria, approximately 2,500 people are affected by multiple myeloma*. For this disease, which used to be almost a death ...
diepresse.com/38640598/multiples-myelom-heilung-in-sicht
J&J enters US robotic surgery market after device gets marketing authorization: Johnson & Johnson said on Wednesday the U.S. Food and Drug Administration had ...
finance.yahoo.com/healthcare/articles/j-j-enters-us-robotic-112150242.html
Johnson & Johnson posts Q2 2026 earnings beat on medicines unit strength
dlvr.it/TTZ0PV
Johnson & Johnson to offer four prescription medicines on TrumpRx website: Johnson & Johnson will start selling four of its medications on the Trump ...
reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-launch-trumprx-with-four-its-prescription-drugs-cbs-news-reports-2026-04-24/
Health is an investment: Austria as a business location. Research pays off threefold: for people, society, and the economy
diepresse.com/20368314/gesundheit-ist-eine-investition
Johnson & Johnson in talks to acquire Protagonist Therapeutics, source says: Johnson & Johnson is in discussions to buy Protagonist Therapeutics ...
reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-talks-acquire-protagonist-therapeutics-wsj-reports-2025-10-10/
Romania Insider Sep 02 25
Bain Capital, Cinven to sell majority stake in Stada, owner of plant in Romania’s Turda
romania-insider.com/stada-ownership-change-sept-2025
Dailynewsegypt Jul 23 25
Egypt’s EDA discusses Johnson & Johnson’s plans to expand investment in local pharmaceutical sector - Dailynewsegypt
dailynewsegypt.com/2025/07/22/egypts-eda-discusses-johnson-johnsons-plans-to-expand-investment-in-local-pharmaceutical-sector/
Johnson & Johnson’s stock surges as tariff-cost estimate is slashed and profit outlook raised
marketwatch.com/story/johnson-johnsons-stock-rallies-after-earnings-beat-and-outlook-raised-amid-strength-in-heart-and-cancer-treatments-5d66f50b
Paid articlePaywall
A Devastating New Exposé of Johnson & Johnson Indicts an Entire System: An investigative history of the scandal-plagued company shines a light on a health care ...
newrepublic.com/article/194726/johnson-and-johnson-investigation-crimes-health-care-system
"Curing serious illnesses one day": Interview. Sara Leitao, Managing Director of Johnson & Johnson Innovative Medicine Austria, on visions for Austria's ...
diepresse.com/19640911/schwere-krankheiten-eines-tages-heilen
Healthy society, healthy working environment: At Johnson & Johnson, progress and cooperation go hand in hand.
diepresse.com/19583323/gesunde-gesellschaft-gesundes-arbeitsklima
Next